• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DriverRWH:通过基因突变超图上的随机游走发现癌症驱动基因。

DriverRWH: discovering cancer driver genes by random walk on a gene mutation hypergraph.

机构信息

School of Mathematics and Statistics, Shandong University, Weihai, 264209, China.

Department of Mathematics, Weifang University, Weifang, 261061, Shandong, China.

出版信息

BMC Bioinformatics. 2022 Jul 13;23(1):277. doi: 10.1186/s12859-022-04788-7.

DOI:10.1186/s12859-022-04788-7
PMID:35831792
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9281118/
Abstract

BACKGROUND

Recent advances in next-generation sequencing technologies have helped investigators generate massive amounts of cancer genomic data. A critical challenge in cancer genomics is identification of a few cancer driver genes whose mutations cause tumor growth. However, the majority of existing computational approaches underuse the co-occurrence mutation information of the individuals, which are deemed to be important in tumorigenesis and tumor progression, resulting in high rate of false positive.

RESULTS

To make full use of co-mutation information, we present a random walk algorithm referred to as DriverRWH on a weighted gene mutation hypergraph model, using somatic mutation data and molecular interaction network data to prioritize candidate driver genes. Applied to tumor samples of different cancer types from The Cancer Genome Atlas, DriverRWH shows significantly better performance than state-of-art prioritization methods in terms of the area under the curve scores and the cumulative number of known driver genes recovered in top-ranked candidate genes. Besides, DriverRWH discovers several potential drivers, which are enriched in cancer-related pathways. DriverRWH recovers approximately 50% known driver genes in the top 30 ranked candidate genes for more than half of the cancer types. In addition, DriverRWH is also highly robust to perturbations in the mutation data and gene functional network data.

CONCLUSION

DriverRWH is effective among various cancer types in prioritizes cancer driver genes and provides considerable improvement over other tools with a better balance of precision and sensitivity. It can be a useful tool for detecting potential driver genes and facilitate targeted cancer therapies.

摘要

背景

下一代测序技术的最新进展帮助研究人员生成了大量的癌症基因组数据。癌症基因组学的一个关键挑战是确定少数导致肿瘤生长的癌症驱动基因。然而,大多数现有的计算方法都没有充分利用个体的共突变信息,这些信息被认为在肿瘤发生和肿瘤进展中很重要,导致假阳性率很高。

结果

为了充分利用共突变信息,我们提出了一种随机游走算法,称为 DriverRWH,它基于加权基因突变超图模型,利用体细胞突变数据和分子相互作用网络数据对候选驱动基因进行优先级排序。将 DriverRWH 应用于来自癌症基因组图谱的不同癌症类型的肿瘤样本,在曲线下面积得分和前 30 名候选基因中恢复的已知驱动基因数量方面,DriverRWH 显著优于最先进的优先级排序方法。此外,DriverRWH 发现了一些潜在的驱动基因,它们在癌症相关途径中富集。DriverRWH 在超过一半的癌症类型中,在前 30 名候选基因中恢复了大约 50%的已知驱动基因。此外,DriverRWH 对突变数据和基因功能网络数据的干扰也具有很高的鲁棒性。

结论

DriverRWH 在各种癌症类型中对癌症驱动基因的优先级排序是有效的,并且在精确性和敏感性之间取得了更好的平衡,优于其他工具。它可以作为检测潜在驱动基因的有用工具,并促进针对癌症的治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3571/9281118/829e28955f8b/12859_2022_4788_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3571/9281118/1ac8a7ed9891/12859_2022_4788_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3571/9281118/7fbc28c7c70c/12859_2022_4788_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3571/9281118/43da8c7c5c47/12859_2022_4788_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3571/9281118/d9040daacf97/12859_2022_4788_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3571/9281118/da6a3e9f470d/12859_2022_4788_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3571/9281118/bec57a500ddf/12859_2022_4788_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3571/9281118/829e28955f8b/12859_2022_4788_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3571/9281118/1ac8a7ed9891/12859_2022_4788_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3571/9281118/7fbc28c7c70c/12859_2022_4788_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3571/9281118/43da8c7c5c47/12859_2022_4788_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3571/9281118/d9040daacf97/12859_2022_4788_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3571/9281118/da6a3e9f470d/12859_2022_4788_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3571/9281118/bec57a500ddf/12859_2022_4788_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3571/9281118/829e28955f8b/12859_2022_4788_Fig7_HTML.jpg

相似文献

1
DriverRWH: discovering cancer driver genes by random walk on a gene mutation hypergraph.DriverRWH:通过基因突变超图上的随机游走发现癌症驱动基因。
BMC Bioinformatics. 2022 Jul 13;23(1):277. doi: 10.1186/s12859-022-04788-7.
2
Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes.癌症基因组中用于优先确定驱动突变和显著突变基因的计算方法进展。
Brief Bioinform. 2016 Jul;17(4):642-56. doi: 10.1093/bib/bbv068. Epub 2015 Aug 24.
3
VarWalker: personalized mutation network analysis of putative cancer genes from next-generation sequencing data.VarWalker:基于下一代测序数据对假定癌症基因进行个性化突变网络分析
PLoS Comput Biol. 2014 Feb 6;10(2):e1003460. doi: 10.1371/journal.pcbi.1003460. eCollection 2014 Feb.
4
Identifying cooperating cancer driver genes in individual patients through hypergraph random walk.通过超图随机游走在个体患者中识别协同致癌驱动基因。
J Biomed Inform. 2024 Sep;157:104710. doi: 10.1016/j.jbi.2024.104710. Epub 2024 Aug 17.
5
The Integrative Method Based on the Module-Network for Identifying Driver Genes in Cancer Subtypes.基于模块网络的癌症亚型驱动基因识别的综合方法。
Molecules. 2018 Jan 24;23(2):183. doi: 10.3390/molecules23020183.
6
LNDriver: identifying driver genes by integrating mutation and expression data based on gene-gene interaction network.LNDriver:基于基因-基因相互作用网络整合突变和表达数据来识别驱动基因。
BMC Bioinformatics. 2016 Dec 23;17(Suppl 17):467. doi: 10.1186/s12859-016-1332-y.
7
MaxMIF: A New Method for Identifying Cancer Driver Genes through Effective Data Integration.MaxMIF:一种通过有效数据整合识别癌症驱动基因的新方法。
Adv Sci (Weinh). 2018 Jul 23;5(9):1800640. doi: 10.1002/advs.201800640. eCollection 2018 Sep.
8
Individualized discovery of rare cancer drivers in global network context.在全球网络环境下,对罕见癌症驱动因素进行个体化发现。
Elife. 2022 May 20;11:e74010. doi: 10.7554/eLife.74010.
9
Ranking cancer drivers via betweenness-based outlier detection and random walks.基于介数的异常点检测和随机游走算法对癌症驱动基因进行排名。
BMC Bioinformatics. 2021 Feb 10;22(1):62. doi: 10.1186/s12859-021-03989-w.
10
SomInaClust: detection of cancer genes based on somatic mutation patterns of inactivation and clustering.SomInaClust:基于失活和聚类的体细胞突变模式检测癌症基因。
BMC Bioinformatics. 2015 Apr 23;16:125. doi: 10.1186/s12859-015-0555-7.

引用本文的文献

1
Enhancing Molecular Network-Based Cancer Driver Gene Prediction Using Machine Learning Approaches: Current Challenges and Opportunities.使用机器学习方法增强基于分子网络的癌症驱动基因预测:当前挑战与机遇
J Cell Mol Med. 2025 Jan;29(1):e70351. doi: 10.1111/jcmm.70351.
2
IMI-driver: Integrating multi-level gene networks and multi-omics for cancer driver gene identification.IMI-driver:综合多层次基因网络和多组学数据进行癌症驱动基因识别。
PLoS Comput Biol. 2024 Aug 26;20(8):e1012389. doi: 10.1371/journal.pcbi.1012389. eCollection 2024 Aug.
3
Identification of cancer driver genes based on hierarchical weak consensus model.

本文引用的文献

1
Identifying driver genes for individual patients through inductive matrix completion.通过归纳矩阵补全鉴定个体患者的驱动基因。
Bioinformatics. 2021 Dec 7;37(23):4477-4484. doi: 10.1093/bioinformatics/btab477.
2
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
3
An Efficient and Easy-to-Use Network-Based Integrative Method of Multi-Omics Data for Cancer Genes Discovery.
基于层次化弱共识模型的癌症驱动基因识别
Health Inf Sci Syst. 2024 Mar 6;12(1):21. doi: 10.1007/s13755-024-00279-6. eCollection 2024 Dec.
4
DriverMP enables improved identification of cancer driver genes.DriverMP 可提高癌症驱动基因的识别能力。
Gigascience. 2022 Dec 28;12. doi: 10.1093/gigascience/giad106. Epub 2023 Dec 13.
5
Identifying Cancer Driver Pathways Based on the Mouth Brooding Fish Algorithm.基于口育鱼算法识别癌症驱动通路。
Entropy (Basel). 2023 May 24;25(6):841. doi: 10.3390/e25060841.
6
DeepAlloDriver: a deep learning-based strategy to predict cancer driver mutations.DeepAlloDriver:一种基于深度学习的癌症驱动突变预测策略。
Nucleic Acids Res. 2023 Jul 5;51(W1):W129-W133. doi: 10.1093/nar/gkad295.
一种用于癌症基因发现的高效且易于使用的基于网络的多组学数据整合方法。
Front Genet. 2021 Jan 8;11:613033. doi: 10.3389/fgene.2020.613033. eCollection 2020.
4
KEGG: integrating viruses and cellular organisms.KEGG:整合病毒和细胞生物。
Nucleic Acids Res. 2021 Jan 8;49(D1):D545-D551. doi: 10.1093/nar/gkaa970.
5
iGMDR: Integrated Pharmacogenetic Resource Guide to Cancer Therapy and Research.iGMDR:癌症治疗与研究的综合药物遗传学资源指南。
Genomics Proteomics Bioinformatics. 2020 Apr;18(2):150-160. doi: 10.1016/j.gpb.2019.11.011. Epub 2020 Sep 8.
6
A compendium of mutational cancer driver genes.癌症驱动基因突变综合分析
Nat Rev Cancer. 2020 Oct;20(10):555-572. doi: 10.1038/s41568-020-0290-x. Epub 2020 Aug 10.
7
: new biomarker and drug target for checkpoint blockade immunotherapy.: 新的生物标志物和药物靶点,用于检查点阻断免疫治疗。
J Immunother Cancer. 2020 Mar;8(1). doi: 10.1136/jitc-2019-000485.
8
Targeting the PI3K/Akt/mTOR pathway in non-small cell lung cancer (NSCLC).针对非小细胞肺癌(NSCLC)中的 PI3K/Akt/mTOR 通路。
Thorac Cancer. 2020 Mar;11(3):511-518. doi: 10.1111/1759-7714.13328. Epub 2020 Jan 27.
9
CancerGeneNet: linking driver genes to cancer hallmarks.癌症基因网络:将驱动基因与癌症特征联系起来。
Nucleic Acids Res. 2020 Jan 8;48(D1):D416-D421. doi: 10.1093/nar/gkz871.
10
Toward understanding the origin and evolution of cellular organisms.为了理解细胞生物的起源和进化。
Protein Sci. 2019 Nov;28(11):1947-1951. doi: 10.1002/pro.3715. Epub 2019 Sep 9.